{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:02:50Z","timestamp":1792414970974,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005378","name":"Hacettepe \u00dcniversitesi","doi-asserted-by":"publisher","award":["TSA-2021-19012"],"award-info":[{"award-number":["TSA-2021-19012"]}],"id":[{"id":"10.13039\/501100005378","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.exer.2024.109833","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T06:11:26Z","timestamp":1708063886000},"page":"109833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Allele-specific antisense oligonucleotides for the treatment of BEST1-related dominantly inherited retinal diseases: An in vitro model"],"prefix":"10.1016","volume":"241","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5564-4813","authenticated-orcid":false,"given":"Beren","family":"Karaosmanoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gozde","family":"Imren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda","family":"Utine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande","family":"Taylan Sekeroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6040-6625","authenticated-orcid":false,"given":"Ekim Z.","family":"Taskiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5806","key":"10.1016\/j.exer.2024.109833_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/290457a0","article-title":"Sequence and organization of the human mitochondrial genome","volume":"290","author":"Anderson","year":"1981","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.exer.2024.109833_bib2","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1038\/s41598-018-22096-0","article-title":"Clinical and genetic characteristics of 251 consecutive patients with macular and cone\/cone-rod dystrophy","volume":"8","author":"Birtel","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2024.109833_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2017.03.003","article-title":"Unravelling the genetics of inherited retinal dystrophies: Past, present and future","volume":"59","author":"Broadgate","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"issue":"9","key":"10.1016\/j.exer.2024.109833_bib4","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ymthe.2018.05.025","article-title":"Retinal AAV8-RS1 gene therapy for X-Linked Retinoschisis: initial findings from a phase I\/IIa trial by Intravitreal delivery","volume":"26","author":"Cukras","year":"2018","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.exer.2024.109833_bib5","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017129","article-title":"Genes and mutations causing autosomal dominant retinitis Pigmentosa","volume":"5","author":"Daiger","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"10","key":"10.1016\/j.exer.2024.109833_bib6","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.3390\/antiox11101967","article-title":"Epitranscriptome analysis of oxidative stressed retinal epithelial cells Depicted a possible RNA editing landscape of retinal degeneration","volume":"11","author":"Donato","year":"2022","journal-title":"Antioxidants"},{"issue":"11","key":"10.1016\/j.exer.2024.109833_bib7","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1089\/hum.2019.132","article-title":"Dual ABCA4-AAV vector treatment reduces pathogenic retinal A2E accumulation in a mouse model of autosomal recessive stargardt disease","volume":"30","author":"Dyka","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.exer.2024.109833_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.794805","article-title":"Gene-based therapeutics for inherited retinal diseases","volume":"12","author":"Fenner","year":"2022","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.exer.2024.109833_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000445782","article-title":"On retinal gene therapy","volume":"236","author":"Fischer","year":"2016","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.exer.2024.109833_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108482","article-title":"RNA therapeutics in ophthalmology - translation to clinical trials","volume":"205","author":"Gupta","year":"2021","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.exer.2024.109833_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.paed.2019.10.004","article-title":"Inherited retinal dystrophies","volume":"30","author":"Henderson","year":"2020","journal-title":"Paediatr. Child Health"},{"key":"10.1016\/j.exer.2024.109833_bib12","article-title":"RNA-targeting strategies as a platform for ocular gene therapy","volume":"92","author":"Kumar","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"issue":"9923","key":"10.1016\/j.exer.2024.109833_bib13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","article-title":"Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial","volume":"383","author":"MacLaren","year":"2014","journal-title":"Lancet (London, England)"},{"issue":"7806","key":"10.1016\/j.exer.2024.109833_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41586-020-2201-4","article-title":"Pharmacologic fibroblast reprogramming into photoreceptors restores vision","volume":"581","author":"Mahato","year":"2020","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.exer.2024.109833_bib15","doi-asserted-by":"crossref","first-page":"12758","DOI":"10.1073\/pnas.220402097","article-title":"Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium","volume":"97","author":"Marmorstein","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"9","key":"10.1016\/j.exer.2024.109833_bib16","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/hmg\/ddy070","article-title":"BEST1 protein stability and degradation pathways differ between autosomal dominant Best disease and autosomal recessive bestrophinopathy accounting for the distinct retinal phenotypes","volume":"27","author":"Milenkovic","year":"2018","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.exer.2024.109833_bib17","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3390\/ijms21051597","article-title":"Mutation-dependent pathomechanisms determine the phenotype in the bestrophinopathies","volume":"21","author":"Nachtigal","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.exer.2024.109833_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.exer.2024.109833_bib19","article-title":"RaNA-Seq: interactive RNA-Seq analysis from FASTQ files to functional analysis","volume":"15","author":"Prieto","year":"2019","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.exer.2024.109833_bib20","first-page":"493","article-title":"Glyoxalase I A111E, paraoxonase 1 Q192R and L55M polymorphisms in Italian patients with sporadic cerebral cavernous malformations: a pilot study","volume":"29","author":"Rinaldi","year":"2015","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"10097","key":"10.1016\/j.exer.2024.109833_bib21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"11","key":"10.1016\/j.exer.2024.109833_bib22","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fgene.2020.00146","article-title":"High-throughput sequencing to detect novel likely gene-disrupting variants in pathogenesis of sporadic brain arteriovenous malformations","volume":"28","author":"Scimone","year":"2020","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.exer.2024.109833_bib23","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/nar\/gkx1239","article-title":"Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs","volume":"46","author":"Shen","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.exer.2024.109833_bib24","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1007\/s13346-022-01138-1","article-title":"Transdermal delivery for gene therapy","volume":"12","author":"Singh","year":"2022","journal-title":"Drug delivery and translational research"},{"issue":"9","key":"10.1016\/j.exer.2024.109833_bib25","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.ophtha.2017.04.008","article-title":"Clinically focused molecular investigation of 1000 consecutive families with inherited retinal disease","volume":"124","author":"Stone","year":"2017","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.exer.2024.109833_bib26","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1136\/bjo-2022-321903","article-title":"Genetic treatment for autosomal dominant inherited retinal dystrophies: approaches, challenges and targeted genotypes","volume":"107","author":"Varela","year":"2022","journal-title":"The British journal of ophthalmology. Br J Ophthalmol"},{"key":"10.1016\/j.exer.2024.109833_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/EB.S9078","article-title":"Energy metabolism of the visual system","volume":"2","author":"Wong-Riley","year":"2010","journal-title":"Eye Brain"},{"issue":"R1","key":"10.1016\/j.exer.2024.109833_bib28","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1093\/hmg\/ddx182","article-title":"Inherited eye-related disorders due to mitochondrial dysfunction","volume":"26","author":"Yu-Wai-Man","year":"2017","journal-title":"Hum. Mol. Genet."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448352400054X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448352400054X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:25:10Z","timestamp":1758000310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448352400054X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":28,"alternative-id":["S001448352400054X"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2024.109833","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allele-specific antisense oligonucleotides for the treatment of BEST1-related dominantly inherited retinal diseases: An in vitro model","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2024.109833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109833"}}